Pain News and Research

Latest Pain News and Research

AcelRx Pharmaceuticals initiates ARX-04 Phase 3 study in emergency room patients with acute pain

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute and breakthrough pain, today announced the initiation of an open-label Phase 3 study (SAP302) of ARX-04 for the treatment of adult patients who present in the emergency room with moderate-to-severe acute pain associated with trauma or injury.

6 Oct 2015

WHO and UNAIDS develop new standards to help countries improve quality of adolescent care

New Global Standards for quality health-care services for adolescents developed by WHO and UNAIDS aim to help countries improve the quality of adolescent health care.

6 Oct 2015

Anti-coagulant medications quickly resolve blood clots that could impair valve motion

Heart valve replacements made from tissue (bioprosthetic valves) have long been thought to be spared the complication of blood clot formation. Researchers have now found that about 15 percent of all bioprosthetic aortic heart valve patients develop blood clots on the leaflets affecting valve opening, regardless of whether the patient received the new valve via open-heart surgery or a minimally-invasive catheter procedure, a new study from the Cedars-Sinai Heart Institute shows.

6 Oct 2015

Social dynamics, family history critical to identifying patients most likely to abuse pain medicines

Patients undergoing rehabilitation for physical injuries and their physicians can better understand who is most at risk of abusing opioids by reviewing their family history, lifestyle and environment for critical cues about susceptibility to addiction, according to physical medicine and rehabilitation experts.

6 Oct 2015

Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Osteopathic physicians, researchers and aligned medical professionals will present clinical and research updates in 15 specialties at OMED 15 in Orlando October 17-21.

6 Oct 2015

Backache awareness week starts 5th October

With BackCare Awareness Week reiterating the fact that 80 per cent of people, who work across all industries and professions, will suffer from back pain at some point in their lives, workplace equipment supplier Slingsby says that nearly all work related back pain can be avoided.

5 Oct 2015

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Allergan plc, a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21. JUVEDERM ULTRA XC instantly adds fullness to the lips and is the only dermal filler that has proven results lasting up to one year for lip augmentation.

1 Oct 2015

Postmenopausal women who are not aware of VVA consequences continue to experience pain during sex

Results from qualitative research of postmenopausal women with vulvar and vaginal atrophy (VVA) show that they recognize the significant physical, emotional and psychological consequences of untreated dyspareunia (painful sex) yet they continue to suffer because of misperceptions about the condition and a general lack of understanding about treatment options.

1 Oct 2015

Patients with advanced lung cancer receive more than recommended number of radiation therapy

Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute.

1 Oct 2015

Brodalumab therapy achieves 100% reduction in psoriasis symptoms

An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers and published online today in the New England Journal of Medicine.

1 Oct 2015

Orlando Health gets Overall 3 Star Rating for bypass surgery and lobectomy

Orlando Health received an Overall 3 Star Rating from The Society of Thoracic Surgeons for quality care provided to patients undergoing bypass surgery and lobectomy for lung cancer.

30 Sep 2015

New review article discusses benefits, limitations of current screening mammography practices

While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.

30 Sep 2015

Stony Brook Children's Hospital follows pain management protocols to treat pain in pediatric patients

Stony Brook Children's Hospital clinicians follow pain management protocols to proactively, preemptively, and consistently treat pain in each and every pediatric patient. Known as the Ouchless Approach to Pediatric Medicine, Margaret McGovern, MD, PhD, Physician-in-Chief, describes it as the cornerstone of treatment for pediatric patients at Stony Brook Children's.

30 Sep 2015

Understanding neurobiological mechanisms of empathy

In a study with more than 100 participants, Claus Lamm and his interdisciplinary team used an innovative experimental trick, the so-called placebo analgesia effect, to close an explanatory gap in the understanding of the neurobiological mechanisms of empathy.

30 Sep 2015

New global educational initiative helps men identify symptoms of advanced prostate cancer

Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.

29 Sep 2015

New global educational initiative helps men identify symptoms of advanced prostate cancer

29 Sep 2015

Promising drug candidate for chronic intractable itch

If you have an itch, you have to scratch it. But that’s a problem for people with a condition called “chronic intractable itch,” where that itchy sensation never goes away—a difficult-to-treat condition closely associated with dialysis and renal failure.

28 Sep 2015

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Braeburn Pharmaceuticals, an Apple Tree Partners company, today announced that the U.S. Food and Drug Administration has accepted Braeburn's resubmission of the Probuphine New Drug Application (NDA) for review and set February 27, 2016 as the target date for Agency action.

28 Sep 2015

Combination of two targeted therapies increases survival in advanced melanoma

Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.

28 Sep 2015

New concussion program aims at treating football players with predisposition to CTE

Upledger Institute Clinic in conjunction with the Ricky Williams Foundation and the Dr. John E. Upledger Foundation announced earlier today, the start of their second concussion therapy research program aimed at treating current and former members of the NFL and the Canadian Football League.

26 Sep 2015

Pain News and Research

Latest Pain News and Research

AcelRx Pharmaceuticals initiates ARX-04 Phase 3 study in emergency room patients with acute pain

WHO and UNAIDS develop new standards to help countries improve quality of adolescent care

Anti-coagulant medications quickly resolve blood clots that could impair valve motion

Social dynamics, family history critical to identifying patients most likely to abuse pain medicines

Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Backache awareness week starts 5th October

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Postmenopausal women who are not aware of VVA consequences continue to experience pain during sex

Patients with advanced lung cancer receive more than recommended number of radiation therapy

Brodalumab therapy achieves 100% reduction in psoriasis symptoms

Orlando Health gets Overall 3 Star Rating for bypass surgery and lobectomy

New review article discusses benefits, limitations of current screening mammography practices

Stony Brook Children's Hospital follows pain management protocols to treat pain in pediatric patients

Understanding neurobiological mechanisms of empathy

New global educational initiative helps men identify symptoms of advanced prostate cancer

New global educational initiative helps men identify symptoms of advanced prostate cancer

Promising drug candidate for chronic intractable itch

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Combination of two targeted therapies increases survival in advanced melanoma

New concussion program aims at treating football players with predisposition to CTE

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in